We have shown that specific cytokine signatures reflect eGC damage (13) and that interleukin 6 (IL-6) plays a causal role in glycocalyx damage in both patients with coronavirus disease 2019 (COVID-19) and those with bacterial sepsis (14). The gene discussed is IL6; the disease is COVID-19.